Pharmaceuticals - Multinational
Abbott India Limited provides diagnostics solutions, medical devices, nutritional products, and pharmaceuticals. Founded in 1910, Abbott India has many years of experience in healthcare. This makes it a longstanding player in the industry. Its headquarters are located in Mumbai, Maharashtra. Main products include diagnostics solutions, medical devices, and pharmaceuticals. Abbott India operates in the healthcare sector. It is contributing significantly to the industry through its diverse product offerings and commitment to innovation and quality. The company also engages in corporate social responsibility initiatives. It supports community development programs and environmental sustainability projects. Read More...
No data available
No data available
No data available
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Total Revenue | 6,097.18 | 5,502.88 | 4,996.48 | 4,390.92 | 4,207.53 |
Total Expenses | 4,479.43 | 4,229.06 | 3,916.75 | 3,464.97 | 3,404.83 |
Profit Before Tax | 1,617.75 | 1,273.82 | 1,079.73 | 925.95 | 802.70 |
Profit After Tax | 1,201.22 | 949.41 | 798.70 | 690.69 | 592.93 |
Operating Profit after Depreciation | 1,630.20 | 1,289.81 | 1,098.83 | 944.23 | 811.23 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Fixed Assets | 224.94 | 236.91 | 271 | 250.78 | 269.83 |
Total Non Current Assets | 1,947.65 | 1,530.40 | 371.08 | 353.04 | 342.20 |
Total Current Assets | 3,245.84 | 3,025.11 | 3,853.04 | 3,487.41 | 3,204.65 |
TOTAL ASSETS | 5,193.49 | 4,555.51 | 4,224.12 | 3,840.45 | 3,546.85 |
Total Shareholder's Fund | 3,698.89 | 3,188.54 | 2,819.79 | 2,602.16 | 2,431.70 |
Particulars (in ₹ Cr.) | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Net Cash from Operating Activities | 1,212.81 | 893.39 | 947.66 | 726.74 | 626.13 |
Net Cash used in Investing Activities | -416.03 | -147.71 | -395.84 | -71.82 | -401.21 |
Net Cash used in Financing Activities | -744.71 | -638.72 | -637.38 | -581.79 | -216.79 |
No data available
Particulars (in ₹ Cr.) | 2024-09 | 2024-06 | 2024-03 | 2023-12 | 2023-09 |
---|---|---|---|---|---|
Total Revenue | 1,632.67 | 1,557.61 | 1,438.63 | 1,437.14 | 1,494.14 |
Total Expenses | 1,193.71 | 1,166.60 | 1,109.10 | 1,049.45 | 1,113.26 |
Profit Before Tax | 479.43 | 437.22 | 389.68 | 422.16 | 415.42 |
Profit After Tax | 358.61 | 328.01 | 287.06 | 310.98 | 312.94 |
Operating Profit after Depreciation | 499.44 | 458.34 | 410.68 | 443.30 | 436.39 |
₹410/Share
Company | Price | Market Cap (in ₹ Cr) |
---|---|---|
Abbott India Ltd | ₹26,094.85 | ₹55,451.56 |
Sun Pharmaceuticals Industries Ltd | ₹1,745.25 | ₹4,18,743.94 |
Divis Laboratories Ltd | ₹5,733.60 | ₹1,52,209.07 |
Cipla Ltd | ₹1,458.15 | ₹1,17,762.24 |
Torrent Pharmaceuticals Ltd | ₹3,357.15 | ₹1,13,616.11 |
Mankind Pharma Ltd | ₹2,488.40 | ₹1,02,663.15 |
28 Jan 2025, 03:04 pm
16 Jan 2025, 01:35 pm
03 Jan 2025, 01:00 pm
03 Jan 2025, 12:59 pm
30 Dec 2024, 01:05 pm
View More